Individualised axitinib regimen for patients with metastatic renal cell carcinoma after treatment with checkpoint inhibitors: a multicentre, single-arm, phase 2 study
2019 ◽
Vol 20
(10)
◽
pp. 1386-1394
◽
Keyword(s):
Phase 2
◽
2015 ◽
Vol 33
(15_suppl)
◽
pp. TPS4579-TPS4579
◽